TickerTain
TickerTain
NewsroomShortsPortfolioConvergence
NewsroomShortsPortfolioConvergence
$ANTHROPIC·$MA····$INTC····$BLUE-ORIGIN·$SPCX····$CRWV····$CRM····$MSFT····$NVDA····$ORCL····$CURSOR·$AAPL····$OPENAI·$AMZN····$UBER····$GOOGL····$META····$TSLA····$DATABRICKS·$PERPLEXITY·$LYFT····$NBIS····$TSM····$LITE····$ANDURIL·
$ANTHROPIC·$MA····$INTC····$BLUE-ORIGIN·$SPCX····$CRWV····$CRM····$MSFT····$NVDA····$ORCL····$CURSOR·$AAPL····$OPENAI·$AMZN····$UBER····$GOOGL····$META····$TSLA····$DATABRICKS·$PERPLEXITY·$LYFT····$NBIS····$TSM····$LITE····$ANDURIL·
←

amine raji

T2 · manager / operator

Former Nestlé employee who experienced microbiology testing pain points firsthand; co-founded Spore.Bio with a physician from Institut Pasteur and a successful French entrepreneur; scaled to 60-person team in Paris with US expansion in 3 years.

1 call·1 name·100% bull·last heard 6 months ago·Scaling Europe
track record

no scored calls yet — needs a stated position or a categorical verdict, with a matured window vs SPY

top calls

highest conviction · one per company
1sthigh conviction
$SPORE-BIOSpore.Bioposition

Spore.Bio launches AI-photonics platform detecting bacteria in 10 minutes without culture

Spore.Bio's TMSI technology combines photonics and a foundation model trained on millions of microbial events to detect, quantify, and identify bacteria in 10 minutes versus 2-14 days for traditional Petri dish methods, targeting a $50B microbiology market and multi-trillion dollar long-term opportunity across clinical, food, pharma, and environmental applications.

Scaling Europe2026-03episode →

most discussed · click a bar to filter

  • $SPORE-BIO

recurring themes

  • AI in Healthcare1
  • Advanced Manufacturing1
  • AI Hardware & Chip Architecture1
  • Life Sciences & Drug Development1
1 total
$SPORE-BIO
Spore.Bio
HIGHamine raji·Scaling Europe·6 months ago·BREAKING: Spore.Bio’s technology can detect bacteria in 10 minutes: Amine Raji, Co-founder & CEO· position
Spore.Bio launches AI-photonics platform detecting bacteria in 10 minutes without culture
Spore.Bio's TMSI technology combines photonics and a foundation model trained on millions of microbial events to detect, quantify, and identify bacteria in 10 minutes versus 2-14 days for traditional Petri dish methods, targeting a $50B microbiology market and multi-trillion dollar long-term opportunity across clinical, food, pharma, and environmental applications.
"today we're announcing the launch and the validation of our proprietary technology TMSI to the whole world, which is the first ever technology that can detect, quantify, and ident…"
0:22
9
AI in Healthcaretailwind
AI-photonics platform replaces 19th-century Petri dish for 10-minute bacteria detection
Spore.Bio's TMSI technology uses light-based spectral signatures and a foundation model trained on millions of microbial events to identify bacteria in 10 minutes without culture, disrupting a $50B microbiology market dominated by 2-14 day incubation methods and enabling real-time quality control in food, pharma, and clinical settings.
8
Advanced Manufacturingtailwind
Real-time microbial monitoring unlocks massive productivity gains for global factories
Reducing contamination testing from days to 10 minutes eliminates inventory holding costs, reduces waste, and enables just-in-time manufacturing for food, beverage, pharma, and cosmetic producers — a multi-trillion dollar addressable market where S&P 500 companies are already pulling for deployment.
8
AI Hardware & Chip Architecturetailwind
Edge AI inference on photonic hardware enables factory-floor microbiology testing
The Spore.Bio machine embeds a GPU for local inference on spectral data, making AI a physical product component rather than a cloud service — a model where photonics (a European strength) captures biological signals and on-device ML classifies them in minutes, creating a defensible hardware-software moat.
7
Life Sciences & Drug Developmenttailwind
Foundation model for microbial spectral signatures expands from bacteria to chemicals and DNA
The same photonics-AI platform trained on bacteria/yeast/mold can be retrained on chemical contaminants, DNA sequences, or any metabolite — creating a universal 'needle in a biological haystack' detector that could replace culture, enrichment, and PCR across clinical diagnostics and environmental monitoring.